United Imaging Debuts Breakthrough AI-Powered Innovations at RSNA 2024
HOUSTON, Dec. 2, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase...
Neurology
Bausch Health Appoints New Chief Medical Officer and Head of R&D
LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment...
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for...
GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices,...
Brainomix Awarded for Its Breakthroughs with Transformative AI Imaging Technology
Two top healthcare awards underline Brainomix's landmark achievements in 2024 and the validation of its software's impact on treatment ratesOXFORD,...
IRM Joins ‘Radiology Reimagined’ Demonstration at RSNA 2024
Collaborative effort highlights integration of AI into radiology workflow SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- IRM Inc., an...
Surgical Robots Market to Grow by USD 14.02 Billion (2024-2028), Rising Adoption for Convenience Drives Growth, Report on AI-Driven Market Transformation – Technavio
NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global surgical robots...
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
Prospective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical...
CLS Health Opens New Comprehensive Care Clinic in Sugar Creek
The physician-owned group expands Houston healthcare services with a multispecialty clinic that puts primary care, cardiology, neurology, lab services, and...
AAMA Installs Jane B. Seelig, CMA-a (AAMA), as 2024–2025 Speaker of the House
GRAND RAPIDS, MI / ACCESSWIRE / November 20, 2024 / The American Association of Medical Assistants® (AAMA) installed Jane B....
LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024...
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
Next generation product may increase gastrointestinal luminal concentration while limiting system exposure LAVAL, QC / ACCESSWIRE / November 18, 2024...
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada’s Drug Agency and Quebec’s INESSS
LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE/TSX:BHC),...
Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,...
FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's...
Inc. Names Arbor Scientia Group as a 2024 Power Partner Award Winner
Award won after analysis of pharmaceutical clients' feedback received by Inc. regarding Arbor Scientia Group's valuable strategic partnerships and tactical support ...
C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) Initiative
C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov....
Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 12, 2024 /PRNewswire/ -- The global artificial intelligence (AI) in drug discovery market is projected to...
Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance
Philips Spectral CT 7500 RT Spectral CT 7500 RT clinical November 12, 2024 Designed specifically for use in radiation oncology,...
MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants
Latest capital raise will accelerate delivery of silicon roadmap to drive next-generation implantable devices for neurological applications LONDON, Nov. 12,...